An object of the present invention is to provide an oral pharmaceutical preparation of aripiprazole that has suppressed sourness and bitterness, imposes less medication burden on patients, has a higher dissolution rate, and enables patients to easily confirm that they have successfully swallowed the preparation. The present invention relates to an oral pharmaceutical preparation comprising aripiprazole and a gelling agent and having a pH of 4.6 or more.